In a challenging market environment, Alector Inc (NASDAQ:ALEC) stock has touched a new 52-week low, with shares plummeting to $1.59. This significant downturn reflects a broader trend for the ...
The U.S. stock market has been showing resilience, with the S&P 500 recently reaching an all-time high and major indices nearing record levels. In this climate, penny stocks—though often ...
Alector, Inc., a late-stage clinical biotechnology company, is advancing its preclinical and research pipeline focused on genetically-validated therapies for neurodegenerative diseases.
Continue to advance preclinical and research pipeline, including key programs selectively combined with Alector Brain Carrier, enhancing the company’s commitment to developing genetically ...
Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) have received a consensus rating of “Hold” from the seven research firms that are presently covering the firm, MarketBeat Ratings reports.
在充满挑战的市场环境下,Alector Inc (ALEC)股价触及新的52周低点,跌至1.59美元。这一显著下跌反映了该生物科技公司的整体趋势,过去一年股价已下跌了75.15%。根据 InvestingPro ...
北京时间2025年01月31日02时20分,Alector, Inc.(ALEC.us)股票出现异动,股价急速拉升5.18%。截至发稿,该股报1.73美元/股,成交量 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results